State and Territory trends

Treatment

Similar trends in treatment initiations were observed for all States and Territories in Australia. Number of individuals initiating treatment were 36101 in New South Wales, 25044 in Victoria, 23595 in Queensland, 10098 in Western Australia, 6606 in South Australia, 2530 in Tasmania, 1490 in Australian Capital Territory, and 962 in Northern Territory. The jurisdictional trends of treatment initiation are illustrated in Figures 10A, 10B and 13. For jurisdictions with smaller populations treated for HCV, the trends were presented on separate panels in Figures 10A and 10B.

Retreatment for treatment failure

There were similar trends in retreatment for treatment failure in all Australian Jurisdictions (Figures 11A, 11B and 14). The estimated number of retreatments for treatment failure were 1712 in New South Wales, 1404 in Victoria, 1216 in Queensland, 561 in Western Australia, 295 in South Australia, 120 in Tasmania, 88 in Australian Capital Territory, and 57 in Northern Territory. For jurisdictions with smaller populations retreated for treatment failure, trends were presented on separate panels in Figures 11A and 11B.

Retreatment for reinfection

Retreatment for reinfection trends varied by Australian Jurisdiction (Figures 12A, 12B and 15). Over the past five years, retreatment for reinfection has increased considerably in New South Wales and Queensland. A notable decline was observed during 2020 to 2021 for New South Wales, followed by a sharp increase from 2022. The estimated number of retreatments for reinfection were 2835 in New South Wales, 1304 in Victoria, 2481 in Queensland, 607 in Western Australia, 184 in South Australia, 125 in Tasmania, 94 in Australian Capital Territory, and 22 in Northern Territory. For jurisdictions with smaller populations retreated for reinfection, trends were presented on separate panels in Figures 12A and 12B.